MedTrace Logo

Treatment of Refractory Angina Pectoris by Shock Wave Therapy

NCT00776568 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2008-10-21

No results posted yet for this study

Summary

The purpose of this study is to determine that extracorporeal shock wave therapy (ESWT) is safe and effective for the treatment of refractory angina pectoris.

Conditions

  • Angina Pectoris

Interventions

PROCEDURE

Extra-corporeal shockwave

Low intensity shock waves are applied as 300 shocks per visit for 09 visits. The treatment visit is carried at week 1, 5 and 9.

DRUG

Anti-hypertensive drugs

ACE inhibitors, Ca channel blockers, Beta blockers, Diuretics, Cholesterol lowering agents and/or other drugs used alone or in combination, as prescribed.

Sponsors & Collaborators

  • UNIQUIP INTERNATIONAL, Pakistan

    collaborator UNKNOWN

  • Universal Research Group

    lead NETWORK

Principal Investigators

  • Prof. Abdul Samad, MD · Karachi Institute of Heart Diseases

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2009-08-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00776568 on ClinicalTrials.gov